Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients.
Eur Urol
; 78(2): 195-206, 2020 08.
Article
in En
| MEDLINE
| ID: mdl-32376136
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Drug Resistance, Neoplasm
/
Feces
/
Gastrointestinal Microbiome
/
Nivolumab
/
Immune Checkpoint Inhibitors
/
Kidney Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Eur Urol
Year:
2020
Document type:
Article
Country of publication: